Open AccessPrognostic Role of Fasting Remnant Cholesterol with In-Stent Restenosis After Drug-Eluting Stent Implantation
Author(s) -
Yinhua Luo,
Shengyu Cui,
Changjiang Zhang,
Rui Huang,
Jinbo Zhao,
Ke Su,
Dan Luo,
Yuanhong Li
Publication year - 2022
Publication title -
international journal of general medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.722
H-Index - 36
ISSN - 1178-7074
DOI - 10.2147/ijgm.s348148
Subject(s) - medicine , restenosis , cardiology , stent , percutaneous coronary intervention , conventional pci , drug eluting stent , risk factor , coronary artery disease , myocardial infarction
In-stent restenosis (ISR) is regarded as a critical limiting factor in stenting for coronary heart disease (CHD). Recent research has shown that fasting residual cholesterol (RC) has been shown to have a substantial impact on coronary heart disease. Unfortunately, there have not been much data to bear out the relationship between RC and ISR. Then, the predictive value of RC for in-stent restenosis in patients with coronary heart disease was analyzed.